Meditation awareness training (MAT) for improved psychological well-being: a qualitative examination of participant experiences.
Edo Shonin, William Van Gordon, Mark D Griffiths
https://pubmed.ncbi.nlm.nih.gov/23377964Actively Recruiting
Led by University of Derby · Updated on 2024-11-19
200
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating the impact of Meditation Awareness Training (MAT), a second-generation mindfulness-based intervention, on quality of life, pain management, and psycho-spiritual wellbeing in people diagnosed with cancer. This study compares MAT to usual treatment in a randomised controlled trial, aiming to understand how incorporating Buddhist wisdom concepts like impermanence and emptiness might offer deeper spiritual and psychological benefits than first-generation mindfulness interventions. The study focuses on reducing psychological distress, improving pain control, and fostering meaningful perspectives on illness to enhance spiritual wellbeing. Participants will be randomly assigned to either the intervention group receiving MAT or a treatment-as-usual control group. The MAT program consists of weekly 2-hour online sessions over 8 weeks, incorporating Buddhist meditative teachings and practices designed to promote mindfulness and spiritual growth. After the initial trial, control group participants will be offered the MAT intervention. The study includes three phases: the randomised controlled trial, qualitative interviews exploring participants' experiences at one and six months after MAT, and analysis of diary entries collected during the intervention. During the study, participants will be assessed at baseline, week 4, week 9 (end of intervention), and six months follow-up. Measures include psychological wellbeing, pain severity, quality of life, spiritual wellbeing, and trait mindfulness, using validated questionnaires such as the Depression, Anxiety, Stress Scale (DASS), McGill Pain Questionnaire, FACIT-Spiritual Well-being scale, and Five Facet Mindfulness Questionnaire. Researchers will also collect demographic and clinical data. The study aims to provide comprehensive insights into MAT's effects on cancer patients' mental and spiritual health over time, with the entire process spanning several months of participation.
CONDITIONS
Effects of a Second-generation Mindfulness-based Intervention on Quality of Life, Pain Management, and Psycho-spiritual Wellbeing in Cancer Patients: A Randomised Controlled Trial
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or virtual)
Duration - 8 weeks
Participants in the intervention group attend weekly 2-hour Meditation Awareness Training sessions for 8 weeks. Participants in the control group continue with their usual treatment without additional intervention.
Weekly sessions for 8 weeks
Duration - 6 months
Participants are assessed to see if the effects of the intervention last over time.
1 visit at 6-month follow-up
Total: 1 location
1
University of Derby
Derby, Derbyshire, United Kingdom, De1
Actively Recruiting
C
Chloe Wells
W
William Van Gordon
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Edo Shonin, William Van Gordon, Mark D Griffiths
https://pubmed.ncbi.nlm.nih.gov/23377964William Van Gordon, Edo Shonin, Mark D Griffiths
https://pubmed.ncbi.nlm.nih.gov/25801660William Van Gordon, Edo Shonin, Thomas J Dunn...
https://pubmed.ncbi.nlm.nih.gov/27885763William Van Gordon, Edo Shonin, Thomas J Dunn...
https://pubmed.ncbi.nlm.nih.gov/28425778Chloe Wells, Sam Malins, Simon Clarke...
https://pubmed.ncbi.nlm.nih.gov/31654533Christina Shennan, Sheila Payne, Deborah Fenlon
https://pubmed.ncbi.nlm.nih.gov/20690112C M Puchalski
https://pubmed.ncbi.nlm.nih.gov/22628416Ellentika Chayadi, Naomi Baes, Litza Kiropoulos
https://pubmed.ncbi.nlm.nih.gov/35834503